We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics promote chemoresistance by mediating lipid metabolism and suppressing pyroptosis in colorectal cancer
Summary
This study found that microplastics can make colorectal cancer cells more resistant to chemotherapy drugs. Cancer cells absorb microplastics through a protein called clathrin, which triggers increased fat absorption and suppresses a cell death pathway that drugs normally rely on. These findings suggest that microplastic accumulation in the gut could potentially interfere with cancer treatment effectiveness.
Microplastics are ubiquitous environmental contaminants worldwide. Although studies have shown their potential to harm human health, the relationship between microplastics and tumors remains unclear. The intestine is the primary site for microplastics absorption, thus the impact of microplastics on colorectal cancer merits further investigation. Our results indicate that the endocytosis protein clathrin, highly expressed in cancer cells, plays a crucial role in the massive ingestion of microplastics. Further research reveals that microplastics ingestion enhances lipid absorption in colorectal cancer cells by activating the NF-κB signaling pathway. Accumulation of lipids, in turn, suppresses pyroptosis by inhibiting NLRP3/Caspase-1/GSDMD axis, thereby promoting cellular drug resistance. Moreover, microplastics accelerate colorectal cancer development in mice and enhance tumor resistance to oxaliplatin. In summary, microplastics regulate lipid metabolism and pyroptosis in colorectal cancer, emerging as a novel contributor to chemotherapy resistance in colorectal cancer against the backdrop of escalating microplastics pollution.
Sign in to start a discussion.
More Papers Like This
Effects of microplastics on chemo-resistance and tumorigenesis of colorectal cancer
For the first time, researchers confirmed the presence of microplastics in human colorectal cancer tissue and showed in animal models that microplastics increased cancer rates and made tumors more resistant to chemotherapy drugs. The study found that microplastics trigger a cell survival mechanism called autophagy that helps cancer cells resist treatment, suggesting plastic pollution could complicate cancer outcomes.
Identification and analysis of microplastics in peritumoral and tumor tissues of colorectal cancer
Researchers examined tumor and surrounding tissue from colorectal cancer patients and found a diverse range of microplastics, including PVC and polyethylene, with tumor tissues containing a greater variety and higher distribution of microplastics than adjacent healthy tissue. A protein called clathrin that helps cells absorb materials was highly active in the cancer tissue, suggesting it may facilitate microplastic uptake and pointing to a potential link between microplastic exposure and colorectal cancer development.
Tumour-infiltrating microplastics disrupt the JAK-STAT-microbiota axis to promote immunotherapy resistance in colorectal cancer
Researchers isolated microplastics from colorectal cancer tumor tissues and blood samples and examined their properties and effects on cancer progression. They found that tumor-infiltrating microplastics disrupted the JAK-STAT signaling pathway and altered gut microbiota composition, potentially reducing the effectiveness of immunotherapy. The study suggests that microplastic presence in tumors may be a factor worth investigating in cancer treatment outcomes.
Microplastics role in cell migration and distribution during cancer cell division
Researchers exposed human colorectal cancer cells to polystyrene micro- and nanoplastics and found the particles persisted inside cells without being eliminated, were passed from parent to daughter cells during division, and significantly increased cell migration -- a key step in cancer spreading. These findings suggest microplastics could act as hidden promoters of tumor progression in the gut, where plastic exposure through food is highest.
DEHP mediates drug resistance by metabolic reprogramming in colorectal cancer cells
Researchers found that the common plasticizer DEHP triggers metabolic reprogramming in colorectal cancer cells, shifting them from glycolysis to oxidative phosphorylation, which promotes tumor growth and decreases sensitivity to the chemotherapy drug fluorouracil.